Transient Ischemic Attack

Clinical Trial Finder

Many patients who experience transient ischemic attacks (TIAs) are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?

Conditions:   Ischemic Stroke;   Peripheral Artery Disease;   Diabetes Mellitus, Type 2
Interventions:   Drug: Clopidogrel;   Drug: Cilostazol
Sponsor:   University of Ioannina
Recruiting - verified December 2016

Epicardial Fat Pads Ablation During Coronary Surgery

Conditions:   Atrial Fibrillation;   Ischemic Heart Disease
Interventions:   Procedure: Coronary artery bypass grafting;   Procedure: Epicardial ganglionated plexi ablation;   Procedure: implantable loop recorder
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified December 2016

The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Ischemic Heart Disease
Interventions:   Drug: Pharmaceutical composition containing botulinum toxin;   Drug: 0.9% normal saline;   Procedure: Coronary artery bypass grafting
Sponsor:   Meshalkin Research Institute of Pathology of Circulation
Recruiting - verified December 2016

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Condition:   Atrial Fibrillation
Interventions:   Drug: Rivaroxaban (Xarelto, BAY597939);   Drug: Phenprocoumon (branded and generics)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Active, not recruiting - verified December 2016

Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke

Condition:   Ischemic Stroke
Interventions:   Drug: clopidogrel;   Drug: Aspirin
Sponsor:   General Hospital of Shenyang Military Region
Not yet recruiting - verified December 2016

Enhanced Detection of Underlying, Covert ATrial Fibrillation Using 7-day Holter Electrocardiogram in Patients With Embolic Stroke of Undetermined Source

Condition:   Stroke
Sponsor:   National Cerebral and Cardiovascular Center
Recruiting - verified December 2016

Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"

Condition:   Thrombosis
Interventions:   Drug: BMS-986141;   Drug: Aspirin;   Other: Placebo
Sponsor:   Bristol-Myers Squibb
Recruiting - verified July 2016

A Study of the ReCor Medical Paradise System in Clinical Hypertension

Conditions:   Hypertension;   Vascular Diseases
Interventions:   Device: The Paradise® Renal Denervation Ultrasound System;   Device: Sham Procedure
Sponsor:   ReCor Medical, Inc.
Recruiting - verified July 2016

Psychoeducation for Transient Ischaemic Attack and Minor Stroke

Conditions:   Transient Ischaemic Attack;   Stroke
Intervention:   Behavioral: Psychoeducation
Sponsors:   University of Nottingham;   The Stroke Association, United Kingdom;   Nottingham University Hospitals NHS Trust
Recruiting - verified October 2016

Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)

Condition:   Stroke
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin (Acetylsalicylic acid, BAY1019036);   Other: Rivaroxaban-Placebo;   Other: Aspirin-Placebo
Sponsors:   Bayer;   Janssen, LP;   Hamilton Health Sciences Cooperation, Population Health Research Institute
Recruiting - verified December 2016

Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD

Condition:   Cervical Artery Dissection
Interventions:   Drug: Acetylsalicylic acid;   Drug: vitamin K-antagonist
Sponsors:   University Hospital, Basel, Switzerland;   University Hospital Inselspital, Berne;   University of Lausanne Hospitals
Recruiting - verified December 2016

Essential Hypotension and Adaptability Registry

Conditions:   Blood Pressure;   Depression;   Panic Attack;   Fibromyalgia;   POTS;   Inappropriate Sinus Tachycardia;   Coronary Heart Disease;   Acute Coronary Syndrome (ACS);   Acute Myocardial Infarction (AMI);   Cerebrovascular Disease (CVD);   Transient Ischemic Attack (TIA);   Atrial Fibrillation;   Diabetes Mellitus;   Cancer;   Systolic Heart Failure;   Diastolic Heart Failure;   Chronic Fatigue Syndrome;   Syncope;   Vasovagal Syncope
Sponsor:   CES University
Recruiting - verified November 2016